Cart
sales@molnova.com
(Rac)-LB-100
CAS No. 2061038-65-9
(Rac)-LB-100( —— )
Catalog No. M33682 CAS No. 2061038-65-9
LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 81 | In Stock |
|
| 5MG | 126 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 312 | In Stock |
|
| 50MG | 458 | In Stock |
|
| 100MG | 667 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1386 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(Rac)-LB-100
-
NoteResearch use only, not for human use.
-
Brief DescriptionLB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation
-
Description(Rac)-LB-100 is the racemate of LB-100. LB-100 is a protein phosphatase 2A (PP2A) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2061038-65-9
-
Formula Weight268.31
-
Molecular FormulaC13H20N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN1CCN(C(C(C2CCC3O2)C3C(O)=O)=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bai X, et al. Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis. Cancer Lett. 2014 Oct 7. pii: S0304-3835(14)00589-8. ?
molnova catalog
related products
-
m-3M3FBS
m-3M3FBS is a phospholipase C (PLC) activator. m-3M3FBS stimulated a transient intracellular calcium concentration ([Ca(2+)](i)) increase in neutrophils.?
-
3α-Aminocholestane
3α-Aminocholestane (5α-Cholestan-3α-amine) is a potent inhibitor of inositol-5'-phosphatase 1 (SHIP1) containing the SH2 structural domain (IC50 : 2.5 μM) for research and immune-related diseases.
-
Raphin1 acetate
Raphin1 acetate is a selective and orally bioavailable regulatory phosphatase PPP1R15B (R15B) inhibitor.Raphin1, a selective inhibitor of R15B.?In cells, Raphin1 caused a rapid and transient accumulation of its phosphorylated substrate, resulting in a transient attenuation of protein synthesis.?
